Sign Up

Sign up for our free newsletters to receive the latest news from our region in your inbox every weekday.

Posted inWorld

THE LANCET: Racism, discrimination, and xenophobia are fundamental drivers of health disparities worldwide

December 8, 2022 – Racism, xenophobia, and discrimination are fundamental influences on health globally, but have so far been overlooked by health researchers, policymakers, and practitioners, according to a new four-paper Series published in The Lancet. Lead author, Professor Delan Devakumar, UCL, says “Racism and xenophobia exist in every modern society and have profound effects on […]

Posted inWorld

The Lancet: 160 million women worldwide have unmet contraception needs

Published in The Lancet journal by the Global Burden of Disease study, the most comprehensive assessment of worldwide contraceptive need and use estimated that over 160 million women and adolescents with need to prevent childbearing remained without contraception in 2019 – despite major increases in use at a global level since 1970. This study provides estimates of […]

Posted inSci/Tech

The Lancet: An estimated 1.2 million people – and potentially millions more – died in 2019 from antibiotic-resistant bacterial infections

January 19, 2022 – More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR). The analysis of 204 countries and territories, published in The Lancet, reveals that AMR […]

Posted inSci/Tech

The Lancet Public Health: Global dementia cases set to triple by 2050 unless countries address risk factors

The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population ageing. The Global Burden of Disease study is the first to provide forecasting estimates for 204 countries worldwide, […]

Posted inSci/Tech

The Lancet: USA failing to reach populations most in need of HIV prevention and treatment as epidemic grows in the South and rural areas

February 22, 2021 – `The USA continues to lag behind other G-7 nations when it comes to controlling its HIV epidemic and is the only high-income country among the top 10 most HIV-affected countries worldwide. The majority of HIV infections are now concentrated in the South and rural areas, where women and minorities are disproportionately […]

Posted inWorld

The Lancet: Without vaccination against 10 diseases, mortality in children under 5 would be 45% higher in low-income and middle-income countries

January 29, 2021 – Vaccinations against 10 major pathogens have a substantial impact on public health in low-income and middle-income countries (LMICs), according to new modelling research published in The Lancet. The study estimated that from 2000 to 2019 vaccinations have prevented 37 million deaths, and that this figure will increase to 69 million deaths for […]

Posted inSci/Tech

The Lancet: Most patients hospitalized with COVID-19 have at least one symptom six months after falling ill

January 11, 2021 – More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet. The cohort study, looking at long-term effects of COVID-19 infection on people hospitalised in Wuhan, China, reveals that the most common symptom to persist is fatigue […]

Posted inUS

The Lancet: No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients

May 22, 2020 – A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19. The study analysed data from nearly 15,000 patients with COVID-19 receiving a combination of any of the four drug […]

Posted inOp-Ed

The Lancet: Reviving the U.S. CDC

May 15, 2020 – The COVID-19 pandemic continues to worsen in the USA with 1·3 million cases and an estimated death toll of 80684 as of May 12. States that were initially the hardest hit, such as New York and New Jersey, have decelerated the rate of infections and deaths after the implementation of 2 […]

Posted inUS

The Lancet: First randomised trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits

April 29, 2020 – Treatment with the antiviral drug remdesivir does not speed recovery from COVID-19 compared with placebo in hospitalised patients who are critically ill, according to the first randomised trial of its kind involving 237 adults (aged 18 and older) from ten hospitals in Wuhan, China, published in The Lancet. Although their study is […]

Posted inSci/Tech

Modelling study estimates impact of relaxing control measures on possible second wave of COVID-19 in China

April 9, 2020 – New modelling research, published in The Lancet journal, suggests that China’s aggressive control measures appear to have halted the first wave of COVID-19 in areas outside Hubei province, the epicentre of the epidemic. However, given the substantial risk of the virus being reintroduced from abroad, and with economic activity increasing, real-time monitoring of […]

Posted inUS

The Lancet: US is one of the worst performing countries on providing a climate fit for children’s future – placing 173rd globally

February 19, 2020 – A landmark Commission report convened by WHO, UNICEF and The Lancet has found the health and future of every child and adolescent worldwide is under immediate threat from ecological degradation, climate change and exploitative marketing practices that push fast food, sugary drinks, alcohol and tobacco at children. No single country is adequately protecting […]

Sign In

We've recently sent you an authentication link. Please, check your inbox!

Sign in with a password below, or sign in using your email.

Get a code sent to your email to sign in, or sign in using a password.

Enter the code you received via email to sign in, or sign in using a password.

Subscribe to our newsletters:


By signing up, you agree to our Terms of Service.